Sickle Cell Disease/Thalassemia

H14539; Allogeneic Stem Cell Transplantation from HLA Matched Unrelated Donors for Patients with Severe Homozygous B 0/+ Thalassemia or Severe Variants of B 0/+ Thalassemia:  This study uses a monoclonal antibody and high dose chemotherapy in combination with allogeneic (unrelated) stem cell transplantation to treat patients with Thalassemia.

H16447; Allogeneic Bone Marrow Transplantation from HLA Identical Related Donors for Patients wth Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, or Hemoglobin SB0/+ Thallassemia:  This study uses a monoclonal antibody and high dose chemotherapy in combination with allogeneic (related) stem cell transplantation to treat patients with Thallassemia.

©2002, Cell And Gene Therapy, Baylor College of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy Email:cagt@bcm.edu
(Modified: September 21st, 2007 - jb)